TrustCore Financial Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$21.5K Hold
793
﹤0.01% 595
2022
Q3
$17K Sell
793
-266
-25% -$6.95K ﹤0.01% 644
2022
Q2
$29K Hold
1,059
﹤0.01% 554
2022
Q1
$35K Hold
1,059
﹤0.01% 543
2021
Q4
$37K Hold
1,059
﹤0.01% 500
2021
Q3
$33K Hold
1,059
﹤0.01% 551
2021
Q2
$39K Hold
1,059
﹤0.01% 510
2021
Q1
$46K Hold
1,059
0.01% 451
2020
Q4
$49K Hold
1,059
0.01% 428
2020
Q3
$35K Hold
1,059
0.01% 425
2020
Q2
$31K Hold
1,059
0.01% 454
2020
Q1
$29K Hold
1,059
0.01% 426
2019
Q4
$36K Hold
1,059
0.01% 424
2019
Q3
$40K Hold
1,059
0.01% 404
2019
Q2
$46K Buy
+1,059
New +$45.3K 0.01% 368
2018
Q3
Sell
-33
Closed -$2K 840
2018
Q2
$2K Hold
33
﹤0.01% 807
2018
Q1
$2K Hold
33
﹤0.01% 641
2017
Q4
$2K Buy
+33
New +$1.52K ﹤0.01% 620

Other funds holding AVNS

TrustCore Financial Services's AVNS Position: Q4 2022 in Review

TrustCore Financial Services held its Avanos Medical (AVNS) position steady in Q4 2022 at 793 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #595.

TrustCore Financial Services first reported a position in AVNS in Q4 2017 and has held it in 18 quarters since. The position peaked at $49K in Q4 2020. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

  • TrustCore Financial Services held 793 shares of Avanos Medical worth $21.5K as of Q4 2022.
  • TrustCore Financial Services left its Avanos Medical share count unchanged in Q4 2022.
  • Avanos Medical made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #595 holding.
  • TrustCore Financial Services first reported a position in Avanos Medical in Q4 2017 and has held it in 18 quarters since.
  • TrustCore Financial Services's Avanos Medical position peaked at $49K in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.